There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Intravenous tissue-type plasminogen activator can be beneficial to some patients when
given within 3 hours of stroke onset, but many patients present later after stroke
onset and alternative treatments are needed.